-1753360817149.webp&w=3840&q=75)
2025 NOSCM | Future Directions in the Management of Small Cell Lung Cancer
Overview
Dr. Paul Bunn discussed the IMpower133 and CheckMate-153 trials, highlighting the efficacy of atezo and durva in SCLC.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Paul Bunn, MD
Date of Release
July 24th, 2025
-1755990775594.webp&w=3840&q=75)
-1755990700517.webp&w=3840&q=75)